Live Varicella Vaccine 0.5ml | Nexipox PFS - Novo

Advanced Varicella (Chickenpox) Immunization

When protecting pediatric and adult patients against the highly contagious varicella-zoster virus (chickenpox), healthcare providers require a proven, stable, and highly immunogenic clinical intervention. The Varicella Vaccine, Live I.P. (commercially recognized as Nexipox) provides targeted, active immunization designed strictly for subcutaneous administration. Marketed by Novo, this single-dose kit with a pre-filled syringe diluent ensures the steady clinical performance necessary for essential immunization schedules.

Why Choose Nexipox for Clinical Immunization?

Shielding patients from chickenpox requires a live, attenuated vaccine that can reliably prompt a robust, long-lasting cellular and humoral immune response. Nexipox stands out in clinical settings due to its specialized "Trehalose Protection" formulation. Trehalose acts as a powerful stabilizing agent, preserving the delicate structure of the live virus during the freeze-drying process and protecting its potency against thermal stress. The inclusion of a pre-filled syringe (PFS) diluent significantly minimizes preparation time and maximizes sterility in busy clinical environments.

Key Product Specifications & Clinical Benefits

Active Immunization: Contains a highly immunogenic, live attenuated strain of the varicella-zoster virus to establish long-term immunity against chickenpox.

Complete Clinical Kit: Supplied as a convenient combination pack containing 1 dose vial of freeze-dried (lyophilized) vaccine alongside a 0.5 ml sterile diluent in a pre-filled syringe (PFS).

Targeted Subcutaneous Delivery: Formulated strictly for Subcutaneous use only, guaranteeing optimal absorption and systemic immune activation.

Enhanced Stability: Formulated with Trehalose Protection to ensure maximum viability of the live vaccine from manufacturing to administration.

Essential Storage & Usage Guidelines

Maintaining the delicate biological integrity of this live vaccine is absolutely vital for its clinical efficacy.

Strict Cold Chain: Store the lyophilized vaccine vial strictly in a refrigerator between 2°C to 8°C (36°F to 46°F). Protect strictly from light.

Preparation: Reconstitute the freeze-dried vaccine only with the supplied 0.5ml sterile diluent in the pre-filled syringe.

Immediate Use: Once reconstituted, the live vaccine must be administered immediately. Discard if not used promptly according to the prescribing information.

Important Notice: Nexipox is a Prescription Drug. It must be prescribed, handled, and administered strictly by a Registered Medical Practitioner in a clinical or hospital setting. Keep all medicines safely out of the reach of children.